Status:
TERMINATED
Impact of COVID-19 Infection During Pregnancy on Newborns and Young Children
Lead Sponsor:
Centre Hospitalier Universitaire Saint Pierre
Collaborating Sponsors:
Institute for Medical Immunology (IMI)
Laboratoire Hospitalier Universitaire de Bruxelles (LHUB)
Conditions:
Pregnancy
Covid-19
Eligibility:
All Genders
Brief Summary
This study aim is to assess impact of COVID-19 infection during pregnancy on outcome of pregnancy, and on developement of the child in early life.
Detailed Description
All pregnant women will be tested for serology during each trimester of pregnancy and at delivery, together with a nasal swab. Children born to women with positive sawb or serology will be followed up...
Eligibility Criteria
Inclusion
- For pregnant women, all women who deliver in the CHU St Pierre, with oral consent.
- For children follow up: children born to positive mothers and matched controls after written consent
Exclusion
- none
Key Trial Info
Start Date :
May 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2022
Estimated Enrollment :
1362 Patients enrolled
Trial Details
Trial ID
NCT04432779
Start Date
May 25 2020
End Date
March 1 2022
Last Update
August 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU SAINT Pierre
Brussels, Belgium, 1000